Nomura Holdings
CPRX icon

Nomura Holdings’s Catalyst Pharmaceutical CPRX Stock Holding History

Nomura Holdings’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-21,083
Closed -$511K – 1546
2025
Q1 		$511K Buy
+21,083
New +$475K ﹤0.01% 1477
2014
Q4 		– Sell
-54,640
Closed -$181K – 2354
2014
Q3 		$181K Buy
54,640
+29,640
+119% +$77.5K ﹤0.01% 2445
2014
Q2 		$63K Buy
+25,000
New +$53.4K ﹤0.01% 2587
2013
Q4 		– Sell
-22,700
Closed -$69K – 2042
2013
Q3 		$69K Buy
+22,700
New +$38.2K ﹤0.01% 2105

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Nomura Holdings's CPRX Position: Q2 2025 in Review

Nomura Holdings sold out of Catalyst Pharmaceutical (CPRX) in Q2 2025, closing a stake of 21,083 shares — an estimated $511K sold.

Nomura Holdings first reported a position in CPRX in Q3 2013 and held it in 4 quarters. The position peaked at $511K in Q1 2025. 365 funds tracked by Wall St. Rank hold CPRX as of Q2 2025.

  • Nomura Holdings reported no remaining Catalyst Pharmaceutical position as of Q2 2025 after selling out during the quarter.
  • Nomura Holdings sold 21,083 Catalyst Pharmaceutical shares in Q2 2025, an estimated $511K.
  • Nomura Holdings first reported a position in Catalyst Pharmaceutical in Q3 2013 and held it in 4 quarters.
  • Nomura Holdings's Catalyst Pharmaceutical position peaked at $511K in Q1 2025.
  • 365 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2025.

Based on Nomura Holdings's 13F filing for Q2 2025, filed 14 Aug 2025.